A carregar...
Apatinib as an optional treatment in metastatic colorectal cancer
Antiangiogenic therapy has shown clinical benefit in metastatic colorectal cancer (mCRC). We aimed to evaluate the efficacy and safety of apatinib in patients who failed standard treatment and to explore potential factors related to its efficacy. A total of 47 patients were enrolled in this retrospe...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736175/ https://ncbi.nlm.nih.gov/pubmed/31464927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016919 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|